Search This Blog

Wednesday, October 30, 2019

United Therapeutics EPS beats by $0.93, beats on revenue

United Therapeutics (NASDAQ:UTHR): Q3 Non-GAAP EPS of $3.83 beats by $0.93; GAAP EPS of $3.01 beats by $0.57.
Revenue of $401.5M (-2.7% Y/Y) beats by $59.22M.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.